However therapeutic attempts to improve MS outcomes through inhibition of TNF signaling proved to instead worsen disease (The Lenercept Multiple Sclerosis Study Group and The University of British Columbia MS/MRI Analysis Group, 1999). Here, TNF is linked to multiple sclerosis.